Hwail Pharm Co (XKRX:061250) Marketable Securities : ₩5,020 Mil (As of Dec. 2023)

View and export this data going back to 2002. Start your Free Trial

What is Hwail Pharm Co Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Hwail Pharm Co's Marketable Securities for the quarter that ended in Dec. 2023 was ₩5,020 Mil.

Hwail Pharm Co's annual Marketable Securities declined from Dec. 2021 (₩50,077 Mil) to Dec. 2022 (₩30,299 Mil) and declined from Dec. 2022 (₩30,299 Mil) to Dec. 2023 (₩5,020 Mil).

Hwail Pharm Co Marketable Securities Historical Data

The historical data trend for Hwail Pharm Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hwail Pharm Co Marketable Securities Chart

Hwail Pharm Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

4,505.01

3,347.51

50,076.69

30,299.50

5,019.67

Hwail Pharm Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Marketable Securities	Get a 7-Day Free Trial															30,299.50	5,000.00	5,000.00	5,203.32	5,019.67

Hwail Pharm Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Hwail Pharm Co (XKRX:061250) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Hwail Pharm Co Marketable Securities Related Terms

Thank you for viewing the detailed overview of Hwail Pharm Co's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Hwail Pharm Co (XKRX:061250) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hwail Pharm Co Ltd (XKRX:061250) » Definitions » Marketable Securities

Traded in Other Exchanges

N/A

Address

904-7, Sangsin-Ri, Hyangnam-Eup, Hwaseong, Gyeonggi, KOR, 445-746

Website

http://www.hwail.com

Hwail Pharm Co Ltd is engaged in manufacturing and distribution of raw materials used in pharmaceutical production. Its products include antitussive expectorants, spasmolytic, stomach function modifier, anti-inflammatory, and others.

Hwail Pharm Co (XKRX:061250) Headlines

No Headlines